As the global community observes World Malaria Day 2026, Emzor Pharmaceutical Industries has highlighted the pressing need for coordinated efforts to combat malaria in Nigeria, which bears 27% of the global disease burden according to the World Health Organization. The company advocates for enhanced local drug manufacturing capabilities and strategic investments in Active Pharmaceutical Ingredients (APIs) to ensure a sustainable supply of malaria treatments. Emzor also stresses the importance of expanding access to life-saving medications for vulnerable populations, underscoring the urgency of addressing this public health challenge.
Related Articles
Don't miss out on breaking stories and in-depth articles.